The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Carly Holdings (ASX:CL8) is set to receive its first delivery of EVs in December
  • The company reports it will learn from competitors’ struggles in explaining why it has waited to move on the EV trend
  • The company will provide a 30-day-EV-trial product offering
  • The NSW Government will also be approached for a $3000 rebate per vehicle
  • Shares are up nearly 15 per cent, trading at 1.5 cents at 1:19 pm AEDT

Microcap car subscription provider Carly Holdings (ASX:CL8) has placed orders for 78 more vehicles to join its fleet – “the majority of which will be electric vehicles”.

The vehicle order, worth around $2.8 million, is underpinned by a $6 million drawdown from a $10 million facility.

Deliveries are expected to hit the warehouse this month, giving Carly users the option to hire an EV starting in early 2024.

Carly will also provide a 30-day-EV-trial product offering.

Learning from competitors

The company is also hopeful that its provision of EVs can help to “remove many of the current anxieties associated” with EVs – reading between the lines, range anxiety.

“We have been patiently waiting for the optimum market conditions, price points and technology maturity,” Carly CEO Chris Noone pre-empted on why the company has only just now forayed into EVs.

“We can now build our EV fleet, informed by our own experience and some of the challenges experienced by other players who may have been too early to market.”

NSW government rebate hopes

Noone reiterated the company remains focused on “profitable growth”.

The company also intends to approach the NSW Government to apply for a $3000 EV rebate for each vehicle.

Shares were up nearly 15 per cent, trading at 1.5 cents at 1:19 pm AEDT.

CL8 by the numbers
More From The Market Online
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next
The words "Market Open" appear stacked atop one another next to ASX company iconography.

ASX Market Open: Ever-extending US loss streak to bleed into red Friday – unless Oz bucks trend again | Jan 3, 2024

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after